Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: a multicentre US study. (opent nieuw venster)

Al-Samkari H, Jiang D, Gernsheimer T, Liebman H, Lee S, Wojdyla M, Vredenburg M, Cuker A

Bron‎: Br J Haematol. 2022;197(3):359-66.

Geïndexeerd‎: PubMed 35179784

DOI‎: 10.1111/bjh.18081

https://pubmed.ncbi.nlm.nih.gov/35179784/ (opent nieuw venster)

Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with idiopathic thrombocytopenic purpura. (opent nieuw venster)

Alpdogan O, Budak-Alpdogan T, Ratip S, Firatli-Tuglular T, Tanriverdi S, Karti S, Bayik M, Akoglu T.

Bron‎: Br J Haematol 1998;103(4):1061-3.

Geïndexeerd‎: PubMed 9886319

https://www.ncbi.nlm.nih.gov/pubmed/9886319 (opent nieuw venster)

Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. (opent nieuw venster)

Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, Fraser GA, Lim W, Kelton JG.

Bron‎: Ann Intern Med 2007;146(1):25-33.

Geïndexeerd‎: PubMed 17200219

https://www.ncbi.nlm.nih.gov/pubmed/17200219 (opent nieuw venster)

Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. (opent nieuw venster)

Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Amini S, Schipperus M, Lim W, Vishnu P, Warner M, Carruthers J, Li N, Lane S, Kelton JG

Bron‎: Lancet Haematol 2020;7(9):e640-8.

Geïndexeerd‎: PubMed 32853584

DOI‎: 10.1016/S2352-3026(20)30227-1

https://www.ncbi.nlm.nih.gov/pubmed/32853584 (opent nieuw venster)

A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. (opent nieuw venster)

Blanchette VS, Luke B, Andrew M, Sommerville-Nielsen S, Barnard D, de Veber B, Gent M.

Bron‎: J Pediatr 1993;123(6):989-95.

Geïndexeerd‎: PubMed 8229536

https://www.ncbi.nlm.nih.gov/pubmed/8229536 (opent nieuw venster)

High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults. (opent nieuw venster)

Borst F, Keuning JJ, van Hulsteijn H, Sinnige H, Vreugdenhil G.

Bron‎: Ann Hematol 2004;83(12):764-8.

Geïndexeerd‎: PubMed 15309522

DOI‎: 10.1007/s00277-004-0908-1

https://www.ncbi.nlm.nih.gov/pubmed/15309522 (opent nieuw venster)

Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. (opent nieuw venster)

British Committee for Standards in Haematology General Haematology Task Force.

Bron‎: Br J Haematol 2003;120(4):574-96.

Geïndexeerd‎: PubMed 12588344

https://www.ncbi.nlm.nih.gov/pubmed/12588344 (opent nieuw venster)

IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP. (opent nieuw venster)

Carcao M, Silva M, David M, Klaassen RJ, Steele M, Price V, Wakefield C, Kim L, Stephens D, Blanchette VS

Bron‎: Blood Adv 2020;4(7):1492-1500.

Geïndexeerd‎: PubMed 32282882

DOI‎: 10.1182/bloodadvances.2019001343

https://www.ncbi.nlm.nih.gov/pubmed/32282882 (opent nieuw venster)

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. (opent nieuw venster)

Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, Wong WS, Cheng G.

Bron‎: N Engl J Med 2003;349(9):831-6.

Geïndexeerd‎: PubMed 12944568

DOI‎: 10.1056/NEJMoa030254

https://www.ncbi.nlm.nih.gov/pubmed/12944568 (opent nieuw venster)

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. (opent nieuw venster)

Ghanima W, Godeau B, Cines DB, Bussel JB.

Bron‎: Blood 2012;120(5):960-9.

Geïndexeerd‎: PubMed 22740443

DOI‎: 10.1182/blood-2011-12-309153

https://www.ncbi.nlm.nih.gov/pubmed/22740443 (opent nieuw venster)

Use of eltrombopag for secondary immune thrombocytopenia in clinical practice. (opent nieuw venster)

González-López TJ, Alvarez-Román MT, Pascual C, Sánchez-González B, Fernández-Fuentes F, Pérez-Rus G, Hernández-Rivas JA, Bernat S, Bastida JM, Martínez-Badas MP, Martínez-Robles V, Soto I, Olivera P, Bolaños E, Alonso R, Entrena L, Gómez-Nuñez M, Alonso A, Yera Cobo M, Caparrós I, Tenorio M, Arrieta-Cerdán E, Lopez-Ansoar E, García-Frade J, González-Porras JR

Bron‎: Br J Haematol 2017;178(6):959-70.

Geïndexeerd‎: PubMed 28573819

DOI‎: 10.1111/bjh.14788

https://www.ncbi.nlm.nih.gov/pubmed/28573819 (opent nieuw venster)

Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. (opent nieuw venster)

Kojouri K, Vesely SK, Terrell DR, George JN.

Bron‎: Blood 2004;104(9):2623-34.

Geïndexeerd‎: PubMed 15217831

DOI‎: 10.1182/blood-2004-03-1168

https://www.ncbi.nlm.nih.gov/pubmed/15217831 (opent nieuw venster)

Romiplostim or standard of care in patients with immune thrombocytopenia. (opent nieuw venster)

Kuter DJ, Rummel M, Boccia R, Macik BG, Pabinger I, Selleslag D, Rodeghiero F, Chong BH, Wang X, Berger DP.

Bron‎: N Engl J Med 2010;363(20):1889-99.

Geïndexeerd‎: PubMed 21067381

DOI‎: 10.1056/NEJMoa1002625

https://www.ncbi.nlm.nih.gov/pubmed/21067381 (opent nieuw venster)

Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. (opent nieuw venster)

Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L, Vianelli N, Avvisati G, Rodeghiero F, Amendola A, Baronci C, Carbone C, Quattrin S, Fioritoni G, D'Alfonso G, Mandelli F; Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) Thrombocytopenia Working Party.

Bron‎: Blood 2007;109(4):1401-7.

Geïndexeerd‎: PubMed 17077333

DOI‎: 10.1182/blood-2005-12-015222

https://www.ncbi.nlm.nih.gov/pubmed/17077333 (opent nieuw venster)

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. (opent nieuw venster)

Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA; American Society of Hematology.

Bron‎: Blood 2011;117(16):4190-207.

Geïndexeerd‎: PubMed 21325604

DOI‎: 10.1182/blood-2010-08-302984

https://www.ncbi.nlm.nih.gov/pubmed/21325604 (opent nieuw venster)

American Society of Hematology 2019 guidelines for immune thrombocytopenia. (opent nieuw venster)

Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF, Kühne T, Kuter DJ, Lim W, McCrae KR, Pruitt B, Shimanek H, Vesely SK

Bron‎: Blood Adv 2019;3(23):3829-66.

Geïndexeerd‎: PubMed 31794604

DOI‎: 10.1182/bloodadvances.2019000966

https://www.ncbi.nlm.nih.gov/pubmed/31794604 (opent nieuw venster)

International consensus report on the investigation and management of primary immune thrombocytopenia. (opent nieuw venster)

Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ.

Bron‎: Blood 2010;115(2):168-86.

Geïndexeerd‎: PubMed 19846889

DOI‎: 10.1182/blood-2009-06-225565

https://www.ncbi.nlm.nih.gov/pubmed/19846889 (opent nieuw venster)

Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. (opent nieuw venster)

Scaradavou A, Woo B, Woloski BM, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB.

Bron‎: Blood 1997;89(8):2689-700.

Geïndexeerd‎: PubMed 9108386

https://www.ncbi.nlm.nih.gov/pubmed/9108386 (opent nieuw venster)